World's Best Scientists 2026 revealed!
Kazuyuki Shimada

Kazuyuki Shimada

D-Index & Metrics

Medicine

D-Index
102
Citations
46299
World Ranking
7561
National Ranking
181

Overview

Kazuyuki Shimada is affiliated with Nagoya University in Japan and has contributed extensively to the fields of medicine, particularly focusing on lymphoma diagnosis and treatment. Their research spans multiple related subfields, including pathology and forensic medicine, oncology, neurology, genetics, and molecular biology.

The scientist has published numerous articles in prominent journals, with a frequent emphasis on hematological malignancies and lymphoma. The main topics of their research include lymphoma diagnosis and treatment, CNS lymphoma diagnosis and treatment, CAR-T cell therapy research, glioma diagnosis and treatment, viral-associated cancers and disorders, chronic lymphocytic leukemia research, and immune cell function and interaction.

Their research has been disseminated in a range of publication venues, including:

  • Blood
  • International Journal of Hematology
  • Hematological Oncology
  • Cancer Science
  • The American Journal of Surgical Pathology

Shimada's recent scientific output includes the following publications:

  • "Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial," 2020, The Lancet Oncology
  • "Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma," 2020, Blood
  • "Current progress and future perspectives of research on intravascular large B-cell lymphoma," 2021, Cancer Science

Frequent collaborators in Shimada's research include:

  • Hitoshi Kiyoi
  • Dai Maruyama
  • Hirokazu Nagai
  • Shigeo Nakamura
  • Motoko Yamaguchi

The scientist's body of work highlights significant inquiry into hematological cancers, notably intravascular large B-cell lymphoma, through clinical trials and molecular research. Their contributions also include studies into immune checkpoint gene alterations and lymphoma treatment protocols, reflecting an interdisciplinary approach encompassing oncology, pathology, and molecular medicine.

Best Publications

  • Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

    Mitsuhiro Yokoyama;Hideki Origasa;Masunori Matsuzaki;Yuji Matsuzawa

  • Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

    Eriko Tateishi-Yuyama;Hiroaki Matsubara;Toyoaki Murohara;Uichi Ikeda

  • Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives A Prospective Study

    Kazuomi Kario;Thomas G. Pickering;Yuji Umeda;Satoshi Hoshide

  • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014)

    Kazuaki Shimamoto;Katsuyuki Ando;Toshiro Fujita;Naoyuki Hasebe

  • Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives

    Kazuomi Kario;Thomas G. Pickering;Takefumi Matsuo;Satoshi Hoshide

  • Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension.

    Shimada K;Kawamoto A;Matsubayashi K;Nishinaga M

  • Erratum: The Japanese Society of hypertension guidelines for the management of hypertension (Hypertension Research (2009) 32 (11-23) DOI: 10.1038/hr.2008.2)

    Toshio Ogihara;Kenjiro Kikuchi;Hiroaki Matsuoka;Toshiro Fujita

  • Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

    Yasushi Saito;Mitsuhiro Yokoyama;Hideki Origasa;Masunori Matsuzaki

  • Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly: Valsartan in Elderly Isolated Systolic Hypertension Study

    Toshio Ogihara;Takao Saruta;Hiromi Rakugi;Hiroaki Matsuoka

  • Japanese society of hypertension (JSH) guidelines for self-monitoring of blood pressure at home.

    Yutaka Imai;Kuniaki Otsuka;Yuhei Kawano;Kazuyuki Shimada

  • Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Japanese Patients 60 Years or Older With Atherosclerotic Risk Factors: A Randomized Clinical Trial

    Yasuo Ikeda;Kazuyuki Shimada;Tamio Teramoto;Shinichiro Uchiyama

  • Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies

    Waleed Alduaij;Andrei Ivanov;Jamie Honeychurch;Eleanor J Cheadle

  • Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives

    Satoshi Hoshide;Kazuomi Kario;Yoko Hoshide;Yuji Umeda

  • The Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension

    Toshio Ogihara;Kenjiro Kikuchi;Toshiro Fujita;Jitsuo Higaki

  • Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial

    Kortaro Tanaka;Yuichi Ishikawa;Mitsuhiro Yokoyama;Hideki Origasa

  • Retrospective Analysis of Intravascular Large B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy As Reported by the IVL Study Group in Japan

    Kazuyuki Shimada;Kosei Matsue;Kazuhito Yamamoto;Takuhei Murase

  • Presentation and management of intravascular large B-cell lymphoma.

    Kazuyuki Shimada;Tomohiro Kinoshita;Tomoki Naoe;Shigeo Nakamura

  • U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: Orthostatic hypertension as a new cardiovascular risk factor

    Kazuomi Kario;Kazuo Eguchi;Satoshi Hoshide;Yoko Hoshide

  • Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

    Junji Hiraga;Junji Hiraga;Akihiro Tomita;Takumi Sugimoto;Kazuyuki Shimada

Frequent Co-Authors

Kazuomi Kario
Kazuomi Kario Jichi Medical University
Uichi Ikeda
Uichi Ikeda Shinshu University
Masafumi Takahashi
Masafumi Takahashi Jichi Medical University
Shigeo Nakamura
Shigeo Nakamura Nagoya University
Tomoki Naoe
Tomoki Naoe Nagoya University
Thomas G. Pickering
Thomas G. Pickering Columbia University
Hiromi Rakugi
Hiromi Rakugi Osaka University
Masunori Matsuzaki
Masunori Matsuzaki Yamaguchi University
Hiroyuki Mano
Hiroyuki Mano University of Tokyo
Takao Saruta
Takao Saruta Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine doesn’t always mean attending traditional medical school. There are several alternative online programs and career paths that offer flexibility and affordability for students interested in healthcare.

For those interested in healthcare data and systems, an online bachelor's in health information management can open doors to roles such as medical records manager or health information analyst. If you prefer administrative work in healthcare, consider enrolling in medical billing and coding online courses, which prepare you for essential roles in clinics, hospitals, and insurance companies.

Nursing also offers strong online study options. Prospective nurse practitioners can find the cheapest np school online to further their clinical skills without breaking the bank. Alternatively, if you have a non-nursing degree and want to quickly transition into the field, explore the cheapest online accelerated bsn programs.

These diverse and affordable online pathways can help you launch a rewarding healthcare career and address the growing demand for skilled professionals in the medical field.

Best Scientists Citing Kazuyuki Shimada

Trending Scientists